SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Ekso Bionics Holdings, Inc. – ‘10-Q’ for 9/30/19 – ‘EX-32.1’

On:  Wednesday, 10/30/19, at 4:28pm ET   ·   For:  9/30/19   ·   Accession #:  1549084-19-7   ·   File #:  1-37854

Previous ‘10-Q’:  ‘10-Q’ on 8/1/19 for 6/30/19   ·   Next:  ‘10-Q’ on 4/30/20 for 3/31/20   ·   Latest:  ‘10-Q’ on 4/29/24 for 3/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/30/19  Ekso Bionics Holdings, Inc.       10-Q        9/30/19   84:7.7M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    622K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
61: R1          Document And Entity Information                     HTML     50K 
19: R2          Condensed Consolidated Balance Sheets               HTML    115K 
43: R3          Condensed Consolidated Balance Sheets               HTML     46K 
                (Parenthetical)                                                  
75: R4          Condensed Consolidated Statements of Operations     HTML     94K 
                and Comprehensive Income (Loss)                                  
62: R5          Consolidated Statements of Stockholders' Equity     HTML    102K 
20: R6          Condensed Consolidated Statements of Cash Flows     HTML    123K 
44: R7          Organization                                        HTML     40K 
73: R8          Basis of Presentation and Summary of Significant    HTML     72K 
                Accounting Policies and Estimates                                
65: R9          Accumulated Other Comprehensive Income (Loss)       HTML     30K 
26: R10         Fair Value Measurements                             HTML     73K 
32: R11         Inventories, net                                    HTML     33K 
77: R12         Revenue Recognition                                 HTML    124K 
48: R13         Investment in Unconsolidated Affiliate              HTML     38K 
25: R14         Accrued Liabilities                                 HTML     54K 
31: R15         Long-Term Debt                                      HTML     64K 
76: R16         Lease Obligations                                   HTML     48K 
47: R17         Capitalization and Equity Structure                 HTML     97K 
24: R18         Stock-based Compensation                            HTML     97K 
33: R19         Income Taxes                                        HTML     26K 
72: R20         Commitments and Contingencies                       HTML     32K 
64: R21         Net Income (Loss) Per Share                         HTML     69K 
18: R22         Segment Disclosures                                 HTML     98K 
46: R23         Related Party Transactions                          HTML     28K 
71: R24         Subsequent Events                                   HTML     28K 
63: R25         Basis of Presentation and Summary of Significant    HTML    105K 
                Accounting Policies and Estimates (Policies)                     
17: R26         Accumulated Other Comprehensive Income (Loss)       HTML     29K 
                (Tables)                                                         
45: R27         Fair Value Measurements (Tables)                    HTML     71K 
74: R28         Inventories, net (Tables)                           HTML     35K 
60: R29         Revenue Recognition (Tables)                        HTML    115K 
49: R30         Accrued Liabilities (Tables)                        HTML     55K 
80: R31         Long-Term Debt (Tables)                             HTML     57K 
29: R32         Lease Obligations (Tables)                          HTML     40K 
22: R33         Capitalization and Equity Structure (Tables)        HTML     77K 
50: R34         Stock-based Compensation (Tables)                   HTML     99K 
81: R35         Net Income (Loss) Per Share (Tables)                HTML     72K 
30: R36         Segment Disclosures (Tables)                        HTML    100K 
23: R37         Organization (Details)                              HTML     56K 
51: R38         Basis of Presentation and Summary of Significant    HTML     55K 
                Accounting Policies and Estimates (Details)                      
78: R39         Accumulated Other Comprehensive Income (Loss)       HTML     35K 
                (Details)                                                        
55: R40         Fair Value Measurements - Fair Value Hierarchies    HTML     38K 
                (Details)                                                        
67: R41         Fair Value Measurements - Change in Level 3         HTML     43K 
                (Details)                                                        
40: R42         Inventories, net (Details)                          HTML     33K 
15: R43         Revenue Recognition - Deferred Revenue (Details)    HTML     41K 
56: R44         Revenue Recognition - Deferred Revenue Activity     HTML     30K 
                (Details)                                                        
68: R45         Revenue Recognition - Additional Information        HTML     41K 
                (Details)                                                        
41: R46         Revenue Recognition - Performance Obligations       HTML     37K 
                (Details)                                                        
16: R47         Revenue Recognition - Disaggregation of Revenue     HTML     61K 
                (Details)                                                        
57: R48         Investment in Unconsolidated Affiliate - Narrative  HTML     63K 
                (Details)                                                        
66: R49         Investment in Unconsolidated Affiliate -            HTML     37K 
                Additional Information (Details)                                 
83: R50         Accrued Liabilities - Schedule of Accrued           HTML     41K 
                Liabilities (Details)                                            
54: R51         Accrued Liabilities - Product Maintenance and       HTML     30K 
                Warranty (Details)                                               
28: R52         Long-Term Debt - Additional Information (Details)   HTML     57K 
36: R53         Long-Term Debt - Debt Repayment (Details)           HTML     47K 
82: R54         Long-Term Debt - Interest Debt Expense (Details)    HTML     36K 
53: R55         Lease Obligations - Additional Information          HTML     36K 
                (Details)                                                        
27: R56         Lease Obligations - Future Minimum Payments         HTML     48K 
                (Details)                                                        
35: R57         Capitalization and Equity Structure - Additional    HTML    113K 
                Information (Details)                                            
84: R58         Capitalization and Equity Structure - Warrants      HTML     68K 
                (Details)                                                        
52: R59         Capitalization and Equity Structure - Valuation     HTML     50K 
                Assumptions (Details)                                            
14: R60         Stock-based Compensation - Additional Information   HTML     52K 
                (Details)                                                        
38: R61         Stock-based Compensation - Stock Option Activity    HTML     80K 
                (Details)                                                        
70: R62         Stock-based Compensation - Valuation Assumptions    HTML     45K 
                (Details)                                                        
59: R63         Stock-based Compensation - RSU Activity (Details)   HTML     44K 
13: R64         Stock-based Compensation - Compensation Expense     HTML     35K 
                (Details)                                                        
37: R65         Commitments and Contingencies (Details)             HTML     39K 
69: R66         Net Income (Loss) Per Share - Earnings Per Share    HTML     50K 
                (Details)                                                        
58: R67         Net Income (Loss) Per Share - Antidilutive Shares   HTML     35K 
                (Details)                                                        
12: R68         Segment Disclosures - Operating Segments (Details)  HTML     46K 
39: R69         Segment Disclosures - Geographical Segments         HTML     31K 
                (Details)                                                        
34: R70         Related Party Transactions (Details)                HTML     30K 
79: XML         IDEA XML File -- Filing Summary                      XML    151K 
42: EXCEL       IDEA Workbook of Financial Reports                  XLSX     94K 
 6: EX-101.INS  XBRL Instance -- ekso-20190930                       XML   2.42M 
 8: EX-101.CAL  XBRL Calculations -- ekso-20190930_cal               XML    213K 
 9: EX-101.DEF  XBRL Definitions -- ekso-20190930_def                XML    615K 
10: EX-101.LAB  XBRL Labels -- ekso-20190930_lab                     XML   1.61M 
11: EX-101.PRE  XBRL Presentations -- ekso-20190930_pre              XML    970K 
 7: EX-101.SCH  XBRL Schema -- ekso-20190930                         XSD    170K 
21: ZIP         XBRL Zipped Folder -- 0001549084-19-000007-xbrl      Zip    230K 


‘EX-32.1’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


Exhibit 32.1
 
CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO
18 U.S.C. SECTION 1350
 
In connection with the Quarterly Report on Form 10-Q of Ekso Bionics Holdings, Inc. (the “Company”), for the quarterly period ended September 30, 2019 as filed with the Securities and Exchange Commission (the “Report”), I, Jack Peurach, President and Chief Executive Officer and principal executive officer, hereby certify as of the date hereof, solely for purposes of 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
 
Dated: October 30, 2019
  
 
 
 
Principal Executive Officer



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/30/198-K
For Period end:9/30/19
 List all Filings 
Top
Filing Submission 0001549084-19-000007   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 10:22:37.1am ET